socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•

    Search News
    Thursday, August 2, 2007

    Tobira Therapeutics Raises $31M
    San Diego and Princeton, New Jersey-based Tobira Therapeutics said last night that it has completed $31M in a Series A financing. The newly created firm is developing treatments for HIV/AIDs. The funding for the company came from Domain Associates and Frazier Healthcare Ventures, which co-led the round, along with Montreux Equity Partners and Canaan Partners. Tobira also said that it has named James Sapirstein as CEO and President. Tobira Therapeutics said that it will focus on clinical development of novel therapies for HIV/AIDS, based on technology and products licensed from Takeda Pharmaceutical Company Limited of Osaka, Japan.
    posted on Thursday, August 2, 2007 (Link to more information)

    Related companies:
    Tobira Therapeutics

    Related stories:
    > Domain Adds Tobira Therapeutics To Portfolio
    > Trius Therapeutics Raises $30M
    > NovaDigm Therapeutics Raises $4M
    > Regulus Therapeutics Raises $20M
    > Trius Therapeutics Finds $20M

    RSS subscri be via emailEmail Twitter


    Previous news:

     Monday, July 6, 2009
    Thursday, July 2, 2009
    Wednesday, July 1, 2009
    Tuesday, June 30, 2009
    Monday, June 29, 2009